Trial · NCT04191616
Adverse events61
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 61
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 16 | 52 | |
| other | Leukopenia | Blood and lymphatic system disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 3 | 52 | |
| other | Neutropenia | Blood and lymphatic system disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 17 | 52 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 16 | 52 | |
| other | Diarrhoea | Gastrointestinal disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 9 | 52 | |
| other | Nausea | Gastrointestinal disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 7 | 52 | |
| other | Vomiting | Gastrointestinal disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 5 | 52 | |
| other | Asthenia | General disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 9 | 52 | |
| other | Fatigue | General disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 12 | 52 | |
| other | Oedema peripheral | General disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 11 | 52 | |
| other | Pyrexia | General disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 8 | 52 | |
| other | COVID-19 | Infections and infestations | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 6 | 52 | |
| other | Upper respiratory tract infection | Infections and infestations | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 6 | 52 | |
| other | Platelet count decreased | Investigations | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 3 | 52 | |
| other | Dehydration | Metabolism and nutrition disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 3 | 52 | |
| other | Hyperglycaemia | Metabolism and nutrition disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 5 | 52 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 3 | 52 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 4 | 52 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 7 | 52 | |
| other | Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | Carfilzomib With Pomalidomide and Dexamethasone (KPd) | 6 | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04191616/events